Fernwood Investment Management, LLC Sage Therapeutics, Inc. Transaction History

Fernwood Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$18.62 - $26.95 $3,146 - $4,554	169 New	169 $3,000
Q4 2018 Feb 12, 2019	SELL	$81.94 - $139.71 $396,343 - $675,777	-4,837 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$152.15 - $192.33 $552,152 - $697,965	-3,629 Reduced 42.87%	4,837 $779,000
Q4 2017 Feb 05, 2018	BUY	$60.72 - $167.34 $4,007 - $11,044	66 Added 0.79%	8,466 $1.39 Million
Q3 2017 Nov 09, 2017	BUY	$61.4 - $88.52 $515,760 - $743,568	8,400	8,400 $523,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fernwood Investment Management, LLC with notifications on news.